mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
3e-06 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
5e-06 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |